‘It’s really complicated’: How Canadian university women students navigate gendered risk and human papillomavirus (HPV) vaccine decision-making

Wyndham‐West, Michelle

doi:10.1080/13698575.2016.1176127

Cited by 4 publications

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Second, this literature also does not address decisionmaking for the HPV vaccine. While there is scholarship present on vaccine decision-making, which includes research on Hepatitis B vaccination (Adams, 2007); HPV vaccine knowledge, attitudes and acceptance among young women (Hopfer & Cliffard, 2011;Katz, Nkala, Dietrich, Wallace, & Bekker, 2013;Thomas, Blumling, & Delaney, 2015;Wyndham-West, 2016); and vaccine hesitancy (Bazylevych, 2011;Closser et al, 2016;Giles-Vernick, Traore, & Bainilago, 2016;Sobo, 2016), this body of work does not touch upon women's precancer experiences and how they come to bear upon HPV vaccine decision-making. Therefore, this research aims to bring together the experiences of a cervical precancer diagnosis and treatment with the decision-making surrounding the HPV vaccine, which may assist in preventing further HPV infections and precancerous cell development.…”

Section: Gaps In the Literature And Research Focusmentioning

confidence: 99%

Betwixt and Between Well and Sick in Cervical Precancer: Canadian Women’s Experiences of Recurring HPV Infections and HPV Vaccination

2018

View full text Add to dashboard Cite

Background This research fuses the experiences of a precancer diagnosis with the decision-making surrounding a vaccine that can protect against human papillomavirus strains that women may not have been exposed to. The interviewee cohort is of note as half the women were in their 30s and 40s and 75% were over the age of 26. These groupings are often overlooked in media discourses and narrative research surrounding human papillomavirus and the human papillomavirus vaccine. Purpose Womens' diagnoses and treatment experiences, including colposcopies, biopsies, and Loop Electrosurgical Excision Procedures, are chronicled to highlight a liminal, precancerous state-one in which they are not deemed healthy, but nor have they been diagnosed with cancer. These are emotion-filled experiences that are ridden with anxiety and fear, but also ones that are structured with self-care strategies to contain human papillomavirus infections and the risk of cervical cancer. Methods Twenty women who attended Sunnybrook Health Sciences Centre's human papillomavirus vaccination clinic were interviewed and their narratives were documented and analyzed to determine their experiences surrounding human papillomavirus infections and precancer as well as their motivations for human papillomavirus vaccination. Results The decision to undergo human papillomavirus vaccination was a self-care strategy that accompanied treatment procedures and was a means to reduce cervical cancer risk. While encouraged with the human papillomavirus vaccine's potential to curb cervical cancer, they had a tempered view of the vaccine and its effectiveness in their cases, given their medical histories. Conclusions The research provides an in-depth accounting of an often overlooked grouping in human papillomavirus and human papillomavirus vaccination research and media discourse which, generally, focuses upon middle-school-aged girls and university-/college-aged women. In addition, the research provides recommendations for practice for cervical precancer diagnoses going forward.

show abstract